gvtcx

Clone Lentiviral Particles or equivalent

Medicines and Healthcare Products Regulatory Agency Published 10 Dec 2018 Contracts Finder

key details

Statusplanning
Category (CPV) 33696500 +2 more
RegionEast of England
SME suitableYes
OCIDocds-b5fd17-026d485d-1c56-4c08-bef2-c3bd718da193

description

The Agency requires to purchase specified Clone Lentiviral Particles or equivalent.

An over view of the requirement is:

"The project is based on genetic modification of macrophage cell lines with two tagged genes with lentiviral particles such as - 1. Sp110 (NM_175397) Mouse Tagged ORF Clone Lentiviral Particle and 2, Arl8b (NM_026011) Mouse Tagged ORF Clone Lentiviral Particle. We would like to perform a proof of concept theory in-vitro for pathogens of our interest. Ideally, we are planning to order reagents middle of January 2018 and in-vitro work would last for 2-3 months. If the proof-of-concept study looks promising we are planning to order more plasmids and perform more in-vitro experiments."

Potential suppliers if they feel they can meet the requirement should email Nawaz.habib@nibsc.org to register an interest.

If no submissions of potential interest are received by close of play 28 December 2018, it is then intended to perform a direct award without competition to the sole supplier we believe can deliver this requirement.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
10 Dec 2018 Planning (planning) · 43450eb3-4284-4749-a2ac-0573f7dbdce3-258229

more from Medicines and Healthcare Products Regulatory Agency

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.